Treatment of choice for angiofibroma is
The options aren't given, but the correct answer is probably laser therapy. Let me think. For facial angiofibromas, the standard treatment is laser ablation, specifically CO2 laser or erbium YAG laser. Surgical excision might be an option, but laser is preferred because it's less invasive and better for the delicate facial skin. Other treatments like electrocautery or cryotherapy could be alternatives, but laser is considered the gold standard here.
Wait, but sometimes they might use topical treatments like sirolimus? No, I think that's more for the underlying TSC. The angiofibromas themselves are usually treated with lasers. So the correct answer should be laser therapy. The other options might be incorrect because they suggest surgical methods or other less effective treatments. For example, if an option was "surgical excision," that's less preferred than laser. If there's an option for "no treatment," that's incorrect unless the question is about when not to treat, but the question is about the treatment of choice.
So the core concept here is the management of angiofibromas in TSC. The treatment of choice is laser ablation. The wrong options would be other modalities that are not first-line. The clinical pearl is to remember that laser therapy is preferred for facial angiofibromas due to precision and minimal scarring.
**Core Concept** Angiofibromas are benign skin lesions associated with Tuberous Sclerosis Complex (TSC). Their treatment focuses on lesion removal with minimal scarring, often via laser therapy due to its precision and efficacy on facial skin.
**Why the Correct Answer is Right** The treatment of choice for angiofibromas is **CO2 laser ablation** or **erbium YAG laser**. These lasers target the fibrous and vascular components of the lesion, allowing precise removal of superficial lesions while preserving surrounding tissue. Laser therapy is preferred over surgical excision for facial lesions due to reduced scarring and better cosmetic outcomes. It also avoids the risks of systemic therapies, which are not indicated for isolated angiofibromas.
**Why Each Wrong Option is Incorrect**
**Option A:** *Surgical excision* is less favorable due to higher scarring risk and is reserved for larger or atypical lesions.
**Option B:** *Cryotherapy* lacks precision and often results in hypopigmentation or scarring, making it unsuitable for facial angiofibromas.
**Option C:** *Topical sirolimus* is used for TSC-associated renal angiomyolipomas, not angiofibromas.
**Clinical Pearl / High-Yield Fact** Remember the **"L" for laser** in angiofibroma management: Laser ablation